JPRN-UMIN000045203已完成未知
ong-term follow-up of patients enrolled in ReRight registry - The ReRight Registry
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with congenital heart disease, post tricuspid valve (TV) surgery, post heart transplantation, wearing ventricular assist device, and poor right heart images.
研究者
相似试验
招募中
不适用
Study of clinical course and prognosis of severe asthma in Korea by long-term follow-upKCT0007960Hanyang University500
尚未招募
不适用
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (TX200-TR101) in a prior clinical study.Renal transplant rejectionAllograft rejection1002766510029149NL-OMON56013Sangamo Therapeutics France SAS8
进行中（未招募）
1 期
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (CAR- Treg therapy, TX200-TR101) in a prior clinical study.Prevention of immune mediated allograft rejection in patients with end-stage renal disease (ESRD) who are tissue typed as HLA-A*02 negative and have received a kidney transplant from an HLA-A*02 positive living donor.MedDRA version: 21.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2022-002440-40-DESangamo Therapeutics France SAS15
招募中
1 期
ong-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)Kidney Transplant RejectionMedDRA version: 21.1Level: LLTClassification code: 10050436Term: Prophylaxis against renal transplant rejection Class: 10042613CTIS2024-512580-31-00Sangamo Therapeutics France30
招募中
1 期
ong-term follow-up of the WAS gene therapy studyTreatment of Wiskott-Aldrich SyndromeMedDRA version: 20.0Level: PTClassification code: 10047992Term: Wiskott-Aldrich syndrome Class: 100000004850CTIS2024-512680-31-00Genethon10